DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Burmester GR, Pannaccione R, Gordon KB et al.
Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn’s disease.
Ann Rheum Dis 2013;
72: 517-524
We do not assume any responsibility for the contents of the web pages of other providers.